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ABSTRACT
Previous work suggested that phosphorylation
of DNA-PKcs at several serine/threonine (S/T)
residues at positions 2609–2647 promotes DNA-
PK-dependent end joining. In an attempt to clarify
the role of such phosphorylation, end joining was
examined in extracts of DNA-PKcs-deficient M059J
cells. Joining of ends requiring gap filling prior to
ligation was completely dependent on complemen-
tation of these extracts with exogenous DNA-PKcs.
DNA-PKcs with either S/T!A or S/T!D substitu-
tions at all six sites in the 2609–2647 cluster also
supported end joining, but with markedly lower
efficiency than wild-type protein. The residual end
joining was greater with the S/T!D-substituted
than with the S/T!A-substituted protein. A specific
inhibitor of the kinase activity of DNA-PK, KU57788,
completely blocked end joining promoted by wild
type as well as both mutant forms of DNA-PK, while
inhibition of ATM kinase did not. The fidelity of end
joining was not affected by the mutant DNA-PKcs
alleles or the inhibitors. Overall, the results support
a role for autophosphorylation of the 2609–2647
cluster in promoting end joining and controlling
the accessibility of DNA ends, but suggest that
DNA-PK-mediated phosphorylation at other sites,
on either DNA-PKcs or other proteins, is at least
as important as the 2609–2647 cluster in regulating
end joining.
INTRODUCTION
DNA-dependent protein kinase, consisting of the catalytic
subunit DNA-PKcs and the end-binding heterodimer Ku,
is a core component of the nonhomologous end-joining
pathway of DNA double-strand break repair. The
primary function of DNA-PK appears to be regulating
the end-joining process, both by sequestering DNA ends
and by catalyzing serine/threonine phosphorylation of
itself as well as other proteins (1,2). In order to assess
the biological signiﬁcance of speciﬁc phosphorylation
events, radiosensitivity and end joining were previously
examined in CHO variants harboring nonphosphorylat-
able S/T!A substitutions at several sites shown to be
targets of DNA-PK-mediated phosphorylation, either
in vivo or in vitro. Data obtained thus far suggest that
whereas phosphorylation of Ku and XRCC4 is dispens-
able (3), phosphorylation of DNA-PK itself, particularly
at T2609, S2612, T2620, S2624, T2638 and T2647 (the
‘ABCDE cluster’) is critical for eﬃcient DSB repair. For
example, single S/T!A substitutions at several of these
sites increase radiosensitivity of cells harboring the mutant
proteins, and tandem substitutions at multiple sites in the
cluster inhibit repair to a greater degree than mutations at
any single site, and confer greater radiosensitivity (4,5).
Particularly intriguing is a DNA-PKcs allele with
S/T!D substitutions at all six sites in the ABCDE
cluster, designed to mimic constitutive phosphorylation
at these sites. In an end-joining assay with puriﬁed Ku
and XRCC4/DNA ligase IV complex (X4L4), this mutant
(hereafter designated DNA-PKcs-D6) promotes ligation
of a cohesive-ended substrate, albeit less eﬃciently than
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an inhibitor of DNA-PK kinase activity, completely
blocks the in vitro end joining promoted by wild-type
DNA-PKcs, wortmannin has no eﬀect on the end joining
promoted by the D6 mutant (6). Thus, in this assay,
DNA-PKcs-D6 appears to substitute for autophosphory-
lated DNA-PKcs, suggesting that phosphorylation
of the ABCDE cluster may be the primary means by
which DNA-PK regulates the end-joining process. In
DNA-PKcs-deﬁcient CHO-V3 cells, ectopic expression
of DNA-PKcs-D6 partially restores radioresistance and
DSB rejoining (5,7), although not as robustly as might be
expected from the in vitro studies.
In an attempt to further elucidate the role of
phosphorylation of the ABCDE cluster, end joining was
examined in whole-cell extracts of DNA-PKcs-deﬁcient
M059J cells supplemented with wild-type and mutant
DNA-PKcs proteins. This experimental system allows
direct examination of DNA end processing and end
joining, in the presence of all the proteins required to carry
out joining of both cohesive and incompatible DNA ends.
The results conﬁrm the importance of the ABCDE cluster
as a DNA-PK phosphorylation target, but suggest that
there are other target phosphorylation sites of equal if not
greater importance.
MATERIALS AND METHODS
Materials
Puriﬁcation of DNA-PKcs from CHO-V3 cell lines
harboring wild-type and mutant human DNA-PKcs
alleles has been described (6). Because the yield of
DNA-PKcs from hamster cells is much lower than from
human cells, DNA-PKcs from HeLa cells (8) was used for
experiments that did not involve direct comparison of
wild-type and mutant alleles. Nevertheless, the properties
of HeLa DNA-PKcs did not appear to diﬀer signiﬁcantly
from those of wild-type DNA-PKcs puriﬁed from V3 cells.
To ensure reproducibility between experiments, initial
frozen aliquots of DNA-PKcs were subdivided into 1ml
aliquots and ﬂash-frozen in the presence of 1.6mg/ml
BSA. Thus, most experiments were performed with DNA-
PKcs that had undergone no more than two freeze–thaw
cycles. Concentrations of DNA-PKcs from V3 cells were
determined by Bradford assay, and the purity and relative
concentrations of the three recombinant alleles were
veriﬁed by quantitation on gels stained with SYPRO
orange (Supplementary Figure 1).
Previous end-joining experiments employed an SV40-
basedshuttleplasmid(pSV56)designedtointroduceaDSB
in a polylinker in the intron of the T-antigen gene (9).
However, because the presence of the SV40 origin reduces
the yield of the plasmid from bacterial cultures, the poly-
linkerregionofpSV56wasexcisedasa625-bpPﬂMI/AvrII
fragment,andclonedintopBR322betweentheEcoRVand
NheI sites (the PﬂMI cut was blunt-ended with T4
polymerase). This 5-kb plasmid, designated pRZ56, was
cut at its unique MluI site, and then subjected to controlled
30 !50 exonucleolytic digestion with T4 polymerase in the
presence of dTTP. This procedure resects each 30-terminal
strand to the ﬁrst thymine in the sequence, resulting in a
10-base 50 overhang at one end and an 11-base 50 overhang
at the other. An unlabeled 13-mer and a 50-
32P-labeled
14-mer, each complementary to one of the 50 overhangs,
were successively ligated into the overhangs, to yield
site-speciﬁcally labeled substrates with partially comple-
mentary (-ACG) overhangs, as described previously (9,10).
Control experiments showed that the oligomers were
ligated onto at least 90% of the overhangs (data not
shown). The labeled plasmid was puriﬁed by agarose
gel electrophoresis, electroeluted, concentrated (Amicon
Centricon 100) and precipitated. Alternatively, the
MluI-cut plasmid was dephosphorylated and 50-end-
labeled with polynucleotide kinase and [
32P]ATP.
DNA-PKcs-deﬁcient M059J cells were obtained from
Dr Joan Allalunis-Turner (Cross Cancer Institute,
Edmonton, Alberta, Canada), and were grown in MEM
alpha (Gibco) containing 10% fetal bovine serum. One
day after reaching conﬂuence, cells were trypsinized, and
washed extensively with serum-containing medium and
PBS. Whole-cell extracts were prepared by hypotonic
swelling and Dounce homogenization as described (10,11),
except that instead of a 3 hypertonic extraction buﬀer,
0.25 volume of a 5 buﬀer (83.5mM Tris-HCl, 1.65M
KCl, 3.3mM EDTA, 1mM dithiothreitol) was added
prior to high-speed centrifugation, to yield a slightly
higher protein concentration. Extracts consistently had a
protein concentration of  12mg/ml (Pierce BCA protein
assay), and extracts from conﬂuent cultures showed
greater end-joining eﬃciency than those from subconﬂu-
ent cultures. Dignam nuclear extracts, prepared as
described previously (12,13), had a concentration of
 5mg/ml.
Kinase inhibitors KU57788 and KU55933 were pro-
vided by Dr Graeme Smith, KUDOS Inc., and were
dissolved in DMSO at concentrations of 2.5 and 10mM,
respectively, and stored at  208C. Inhibitors were further
diluted in DMSO and added directly to cell extracts
within 1h.
End-joining assay
Reactions contained 50mM triethanolamine–KOH
pH 7.5, 1mM ATP, 1mM dithiothreitol, 1.3mM magne-
sium acetate and dNTPs (or ddNTPs) at 100mM each.
Typically, a 16-ml reaction contained 10ml of extract,
resulting in a ﬁnal concentration of 66mM potassium
acetate and 16% glycerol, and an eﬀective Mg
þþ
concentration of 1mM (taking into account  0.3mM
EDTA from the extract). Buﬀer components were ﬁrst
mixed with cell extract at 228C. DNA-PKcs and/or kinase
inhibitors were then added and the solution mixed by
pipeting. Finally, 10ng substrate was added and the
reaction again mixed by pipeting, and placed in a 378C
water bath, usually for 1 or 6h. Samples were deprotein-
ized as described (10) and either loaded directly onto 0.8%
agarose gels, or cut with BstXI and TaqI and analyzed
on 20% polyacrylamide DNA sequencing gels. Storage
phosphor screens were exposed to frozen polyacrylamide
or dried agarose gels, and images were analyzed with
ImageQuant 3.3 software.
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Accurate joining ofincompatible or cohesive DNA ends
in M059Jextracts requires catalytically active
DNA-PKcs but notATM
As demonstrated previously, human whole-cell extracts
contain robust activity for joining of both cohesive and
incompatible DNA ends (10,11,14). When end-joining
reactions are performed in the presence of relatively low
Mg
þþ concentrations, the joining is largely dependent on
core end-joining factors such as DNA-PKcs, XRCC4,
DNA ligase IV (11,15) and, in the case of incompatible
ends, DNA polymerase  (12).
To assess the dependence of end joining on DNA-PKcs,
and speciﬁcally on DNA-PKcs kinase activity, whole-cell
extracts were prepared from DNA-PKcs-deﬁcient M059J
glioma cells (16). Western blotting (not shown) conﬁrmed
absence of DNA-PKcs in these extracts. End joining of an
internally labeled substrate with partially complementary
(-ACG) 30 overhangs was then examined in these extracts
either with or without addition of puriﬁed DNA-PKcs
from HeLa cells (Figure 1).
When this substrate was incubated in M059J extracts,
and then cut with BstXI and TaqI to release short
fragments from opposite ends of the plasmid, there was
some 30 !50 exonucleolytic digestion, but no ligation
products were detectable (Figure 1B). Supplementation of
the extracts with DNA-PKcs resulted in appearance of
prominent 42- and 24-base labeled products. As demon-
strated previously (10), these products reﬂect ‘accurate’
head-to-tail (42-mer) and head-to-head (24-mer) end
joining by a mechanism involving annealing of the
overhangs, ﬁll-in of the resulting one-base gap, and
ligation (Figure 1A). Although traces of 34- to 38-base
products, corresponding to small deletions in the repair
joints, were detected, the accurate products consistently
accounted for at least 90% of the end joining. Using
various batches of cell extract, 4–20% of the initial DNA
ends were accurately joined. The speciﬁc DNA-PK
inhibitor KU57788 (aka NU7441) (17) completely blocked
formation of both accurate products at a concentration
of 1mM, as did the less speciﬁc DNA-PKcs inhibitor
wortmannin at a concentration of 3mM (Figure 1C). A
speciﬁc inhibitor of ataxia-telangiectasia-mutated (ATM)
Figure 1. Requirement for catalytically active DNA-PK in end joining of a substrate with partially complementary 30 overhangs. The internally
labeled (asterisk) substrate shown (10ng) was incubated for 6h in whole-cell extracts (120mg) or nuclear extracts (30mg) from DNA-PKcs-deﬁcient
M059J cells. Extracts were supplemented with puriﬁed human DNA-PKcs from HeLa cells and/or recombinant X4L4 as indicated. DNA was then
cut with BstXI and TaqI and analyzed on denaturing sequencing gels. (A) Internally labeled substrate and expected end-joining products. The bolded
‘T’ indicates ﬁll-in of the 1 base gap in each strand of the aligned ends. (B) End joining by whole-cell extracts supplemented with 0, 3, 6 or 10nM
DNA-PKcs, or nuclear extracts supplemented with 0, 3 or 6nM DNA-PKcs plus 20nM X4L4 as indicated. (C) Inhibition of end joining in the
presence of 6nM DNA-PKcs by the DNA-PK inhibitors KU57788 (1mM) and wortmannin (3mM). Samples contained 1.2% DMSO as indicated.
(D) Eﬀect of the ATM inhibitor KU55933; same conditions as (C) except that all samples contained 1.2% DMSO. (E) Quantitative data from
experiments similar to that shown in (D); the extent of accurate end joining was calculated as the sum of the 24- and 42-base fragments divided by
the total phosphorimage intensity in each lane, then normalized to the end joining seen in the presence of DNA-PKcs and DMSO without any
inhibitor. Error bars indicate SEM of four measurements, each from a separate experiment except the 10mM point, which was from two
measurements.
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expected to completely inhibit ATM kinase activity
(0.2–1mM, Figure 1D and E). However, it did partially
inhibit end joining at 10mM, a concentration expected to
aﬀect DNA-PK as well (18). DMSO (solvent for all these
inhibitors) had only a slight inhibitory eﬀect (520%) on
the eﬃciency of end joining. These results conﬁrm the
requirement for DNA-PKcs, and for its kinase activity,
in the joining of incompatible ends by human whole-cell
extracts. Similar DNA-PKcs dependence was seen in
nuclear extracts, except that, as reported previously (19),
signiﬁcant end joining was only seen when extracts were
also supplemented with puriﬁed X4L4 (Figure 1B).
However, whole-cell extracts were used for all subsequent
experiments because supplemented nuclear extracts gave
lower yields (2–3%) of end-joined products, and showed a
trace of X4L4-dependent end joining in the absence of
DNA-PKcs. This latter result, which is reminiscent of
studies showing accurate end joining of gapped DSB
substrates in extracts of DNA-PKcs-deﬁcient CHO strains
(10,20), could be explained either by the presence in
human whole-cell extracts of factors whose inhibitory
eﬀect is abrogated by DNA-PK, or the presence in nuclear
extracts of factors that can substitute for DNA-PK in
promoting end-to-end synapsis.
DNA-PKcs-supplemented M059J extracts were also
capable of joining a 50-end labeled cohesive-end substrate
(Figure 2A). Consistent with simple cohesive-end ligation,
such joining yielded exclusively 16-base (head-head),
46-base (tail-tail), 30-base and 36-base (both head-tail)
labeled fragments, which comigrated with products
generated by treatment with T4 ligase (not shown). For
this substrate, the incubation time was reduced to 1h,
which avoided signiﬁcant loss of 50 label but did not
signiﬁcantly decrease the extent of joining (data not
shown). Although a trace of cohesive end joining was
sometimes detected in unsupplemented extracts, DNA-
PKcs addition consistently increased end joining by at
least 15-fold. As with the gapped substrate, KU57788
blocked end joining at concentrations expected to inhibit
DNA-PKcs, with half-maximal inhibition at  0.02mM
and complete inhibition at 1mM (Figure 2B and C).
Again, the ATM inhibitor KU55933 had no eﬀect at
concentrations expected to inhibit ATM [Ki 0.013mM,
ref. (18)], but did block end joining at the extremely high
concentrations expected to inhibit DNA-PK as well
(Ki 2.5mM) (Figure 2C). These results indicate that
joining of DSBs with cohesive as well as incompatible ends
in human cell extracts is completely dependent on
catalytically active DNA-PK but not ATM.
DNA-PKcs proteins withmutations atautophosphorylation
targetsites show reduced proficiency inend joining
To determine whether the observed requirement for
DNA-PKcs kinase activity reﬂects a requirement for
autophosphorylation of the S/T 2609–2647 cluster, end
joining was examined in M059J cells supplemented with
either wild-type DNA-PKcs or DNA-PKcs proteins
having either S/T!A (A6) or S/T!D (D6) substitu-
tions at all six sites in the ABCDE cluster. To ensure
consistency, all three proteins were expressed in and
puriﬁed from CHO-V3 cells, and previous work showed
that they all have comparable kinase activity (6,7).
Figure 3 shows end joining of the 1-base-gapped
substrate in extracts supplemented with these wild-type
and mutant DNA-PKcs proteins. DNA-PKcs-D6,
designed to mimic constitutive phosphorylation of the
ABCDE cluster, supported end joining, but with markedly
lower eﬃciency than the wild-type protein (Figure 3A and
B). The S/T!D mutations did not aﬀect the ﬁdelity of
end joining, as the accurate 42- and 24-base products were
formed almost exclusively. DNA-PKcs-A6 also supported
end joining, but even less eﬃciently than the D6 mutant.
Nevertheless, even at the lowest concentration of DNA-
PKcs-A6, joining was signiﬁcantly greater than that seen
with no DNA-PKcs (0.5% versus50.05%). Moreover, in
three replicate experiments, the diﬀerence between the D6
and A6 alleles was consistently more pronounced at 8nM
than at 2–4nM (Figure 3B).
The formation of accurate repair products from the
gapped substrate requires two end-processing steps,
gap ﬁlling and ligation. To determine the eﬀect of
the phosphorylation site mutations speciﬁcally on the
gap-ﬁlling step, end-joining reactions were performed in
the presence of ddTTP rather than dTTP. As expected,
in the presence of wild-type DNA-PKcs, ddTTP resulted
in the generation of a 15-mer, corresponding to a single-
base-elongated but unligated intermediate, accompanied
by a decrease in intensity of the 42- and 24-base ligation
products (Figure 3C). The residual 42- and 24-mer
products presumably reﬂect gap ﬁlling by residual dTTP
in the cell extracts (extracts were dialyzed for only 3h
(11)). With the D6 and A6 mutant forms of DNA-PKcs,
there was little if any apparent gap ﬁlling. If the extent of
gap ﬁlling were comparable to that of overall end joining,
the 15-mer intermediate might not be detected due to its
proximity to the dominant 14-mer band corresponding to
the initial substrate. In any case, however, the mutant
proteins are clearly much less eﬃcient in promoting gap
ﬁlling on aligned DSB ends than is wild-type DNA-PKcs.
To examine the eﬀect of phosphorylation site mutations
speciﬁcally on the ligation step, similar end-joining assays
were performed with a simple 50-end-labeled substrate
bearing cohesive 4-base (CGCG-) 50 overhangs (Figure 4).
The results were very similar to those obtained with the
substrate requiring gap ﬁlling; that is, the D6 mutant was
markedly less eﬃcient in promoting ligation than wild-
type DNA-PKcs, and the A6 mutant was even less eﬃcient
than the D6 mutant (Figure 4A and B). Thus, end joining
of a substrate requiring only simple religation appears to
be just as dependent on the availability of phosphoryla-
tion sites in the ABCDE cluster, as end joining of a
substrate requiring more complex processing. Thus, gap
ﬁlling, ligation and end joining overall, show roughly the
same relative dependence on ABCDE phosphorylation,
consistent with the model previously proposed (6,7) in
which phosphorylation of the ABCDE cluster promotes
some conformational or other change that increases
accessibility of DNA ends and thereby facilitates both
gap ﬁlling and ligation.
3872 Nucleic Acids Research, 2007, Vol. 35, No. 12End joining promoted by mutantDNA-PKcs proteins is still
dependent on DNA-PK-catalyzed phosphorylation
The ﬁnding that the D6 mutant promotes end joining
more eﬃciently than the A6 mutant, is consistent with
a model wherein the S/T!D mutations mimic phos-
phorylation of the ABCDE cluster (albeit imperfectly)
and promote a similar conformational change in
DNA-PKcs. To assess whether this was the only essential
DNA-PK-mediated phosphorylation event, joining of
both cohesive and incompatible DNA ends was examined
in the presence of M059J extracts, mutant DNA-PKcs
proteins and the DNA-PKcs inhibitor KU57788. With the
gapped DSB substrate, KU57788 completely blocked
the end joining promoted by wild-type DNA-PKcs
as well as both the A6 and the D6 mutants (Figure 3C
and D). Similarly, KU57788 reduced end joining of the
Figure 2. Requirement for catalytically active DNA-PK in end joining of a substrate with cohesive 50 overhangs. MluI-cut pRZ56 was 50-
32P-end-
labeled (asterisk) and incubated for 1h in whole-cell extracts containing 6nM puriﬁed DNA-PKcs and inhibitors as indicated. (A) Denaturing
sequencing gel showing products formed. (B) Agarose gel showing titration of inhibition by KU57788. (C) Quantitation of inhibition of end joining
of the cohesive end substrate by KU57788 (ﬁlled circle) or by the ATM inhibitor KU55933 (ﬁlled square). Error bars show range of values obtained
in two independent experiments. A single titration for KU57788 with the partially complementary substrate (see Figure 1) is shown for comparison
(open triangle). Note that since a single joining event results in both the joined and unjoined ends of a single plasmid migrating as a dimer, the
agarose gel assay results in higher apparent levels of end joining than the sequencing gel assay.
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3874 Nucleic Acids Research, 2007, Vol. 35, No. 12cohesive-end substrate in the presence of either mutant to
the extremely low level seen in the absence of DNA-PKcs
(Figure 4C and D). This complete inhibition by KU57788
was conﬁrmed in at least three independent experiments
with each substrate and each of the three DNA-PKcs
alleles. Thus, mimicking ABCDE phosphorylation
with S/T!D substitutions was not suﬃcient to promote
end joining in the absence of DNA-PKcs activity.
These results suggest that there are target sites for
DNA-PKcs-mediated phosphorylation, other than the
ABCDE cluster, that are important if not essential for
end joining.
In assays with the substrate bearing 30 overhangs,
30 !50 exonucleolytic processing in cell extracts is also
apparent. Although the nuclease responsible for this
digestion has not been identiﬁed, it nevertheless provides
an independent measure of DNA end accessibility.
Despite some variability between diﬀerent batches of cell
extract, exonucleolytic processing was consistently greater
with the D6 than with the A6 mutant, consistent with
phosphorylation of the ABCDE cluster playing an
important role in controlling DNA end accessibility
(Figure 3C). Nevertheless, KU57788 reduced exonucleo-
lytic processing with all three DNA-PKcs alleles, suggest-
ing that DNA-PK-mediated phosphorylation of sites
outside the ABCDE cluster contribute to regulation of
end accessibility.
DISCUSSION
Several lines of evidence suggest that DNA-PKcs
autophosphorylation in the ABCDE cluster plays an
important role in promoting nonhomologous end joining.
When nonphosphorylatable S/T!A substitutions are
introduced at all six sites in the cluster, DNA-PKcs no
longer stimulates ligation of cohesive ends by X4L4 (6).
Moreover, CHO cells harboring the same DNA-PKcs-A6
allele are even more radiosensitive than cells lacking
DNA-PK entirely (5). Both these results are consistent
with the proposed model wherein autophosphorylation of
these sites induces a conformational change in DNA-PKcs
that increases accessibility of DNA ends to speciﬁc end-
processing enzymes such as polymerase  and ligase IV,
thus allowing end joining to proceed to completion.
However, the A6 mutant does support a low level of
Artemis-mediated hairpin opening and V(D)J coding joint
formation, suggesting some residual activity (though
perhaps only in the hairpin cleavage step) (5). The
coding joints formed in cells expressing this mutant are
more similar to those formed in wild-type than in DNA-
PKcs-deﬁcient cells, but show even less nucleotide loss
from the ends (consistent with constitutive end sequestra-
tion), and completely lack any microhomology-based
joining.
Conversely, a mutant with S/T!D substitutions at the
same six sites promotes ligation of cohesive ends by
puriﬁed X4L4, albeit less eﬃciently than the wild-type
DNA-PKcs, even when DNA-PK kinase activity is
blocked (6). When expressed in DNA-PKcs-deﬁcient
CHO cells, DNA-PKcs-D6 largely restores normal
V(D)J recombination, and partially rescues radioresis-
tance (5). Both these results suggest that the S/T!D
substitutions mimic DNA-PKcs autophosphorylation to a
considerable extent, though perhaps not perfectly.
While all of these studies strongly suggest an important
role for phosphorylation of the ABCDE cluster in both
V(D)J recombination and DSB repair, they do not address
the issue of whether such phosphorylation is suﬃcient to
promote these processes, or whether other sites of DNA-
PK-mediated phosphorylation exist that are of equal or
greater importance. These results also do not indicate
whether quantitative diﬀerences between DNA-PKcs
alleles in restoring radioresistance reﬂect qualitative
diﬀerences in the types of DSBs that can be eﬀectively
processed by each allele. In intact CHO cells, complete
DNA-PKcs deﬁciency reduces DSB rejoining by only
 40%, whereas replacement of DNA-PKcs with DNA-
PKcs-A6 reduces rejoining by  50% (5). These results
suggest that some DSBs are repaired by alternative DNA-
PK-independent mechanism(s) (21) that are partially
inhibited by DNA-PKcs-A6, probably because it fails to
dissociate from unrepaired DSBs (7). In the whole-cell
extract assay, however, the low Mg
þþ concentration
restricts end joining to the ligase IV-mediated pathway
(15), and thus accurate joining of the substrate requiring
gap ﬁlling is absolutely dependent on DNA-PKcs
(Figure 1). This stringency allowed the detection of a
small amount of residual accurate joining promoted by
DNA-PKcs-A6 (Figure 3), reminiscent of the low level of
restored V(D)J recombination in cells expressing this allele
(5). Thus, at least in cell extracts, DNA-PKcs does have
some residual activity in promoting end joining, even
when phosphorylation of the ABCDE cluster is com-
pletely abolished. This residual activity, like that seen
with wild-type DNA-PKcs, is still blocked by KU57788,
and therefore must require DNA-PK-mediated phosphor-
ylation of sites outside the ABCDE cluster, either on
DNA-PKcs itself or on other proteins. The results suggest
that once these phosphorylations occur, DNA-PKcs-A6
either dissociates from some DNA ends (5), or can adopt a
conformation that permits some end processing.
The level of end joining promoted by DNA-PKcs-D6 in
cell extracts, greater than DNA-PKcs-A6 but typically
2- to 5-fold lower than wild type (Figure 3), is in
reasonable agreement with its 2-fold lower activity in
promoting ligation by puriﬁed X4L4 (6), as well as
with its ability to partially restore radioresistance ( 50%)
and DSB rejoining ( 20%) to DNA-PKcs-deﬁcient V3
cells (5,7). However, in previous work wortmannin had
no eﬀect on the ability of the D6 allele to promote
X4L4-mediated ligation (6). Thus, the ﬁnding that the
more speciﬁc inhibitor KU57788 completely blocks the
ability of DNA-PKcs-D6 to promote end joining in cell
extracts (Figures 3 and 4), was unexpected. The simplest
explanation for these conﬂicting results is that the
presence of other proteins at DNA ends in cell extracts
(e.g. XLF, Artemis and/or the Mre11/Rad50/NBS
complex) confers a requirement for additional phosphor-
ylation events, besides DNA-PKcs phosphorylation in the
ABCDE cluster—events that are apparently dispensable
in the simpler reaction with DNA-PK and X4L4 only.
Nucleic Acids Research, 2007, Vol. 35, No. 12 3875Figure 4. Promotion of end joining of a cohesive-end substrate by wild-type and mutant alleles of DNA-PKcs. The substrate shown in Figure 2 was
endlabeled and incubated for 1h in extracts supplemented with the wt, A6 and D6 DNA-PKcs alleles. (A) Agarose gel analysis of end joining in the
presence of each DNA-PKcs allele at 0, 2, 4 or 8nM. (B) Concentration dependence of end joining with the wild-type (ﬁlled circle), A6(ﬁlled square)
and D6 (ﬁlled triangle) alleles. Error bars show range of values obtained in two independent experiments when larger than the symbols; the 13nM
point was from a single experiment due to the large amount of DNA-PKcs required. (C) Eﬀect of KU57788 (1mM) on end joining with each
DNA-PKcs allele (4nM). (D) Same as C., except analysis was by BstXI/TaqI cleavage and denaturing sequencing gel electrophoresis.
3876 Nucleic Acids Research, 2007, Vol. 35, No. 12On the other hand, the failure of the D6 mutant to fully
substitute for the wild-type protein in both in vitro and
in vivo assays is not particularly surprising, and is
consistent with a model wherein optimum end joining
requires properly timed interconversion between phos-
phorylated and nonphosphorylated forms of DNA-PKcs.
(There is, however, the formal possibility that S/T!D
substitutions do not fully mimic phosphorylated S/T
residues, and that if fully ABCDE-phosphorylated
DNA-PKcs could be generated, it would promote some
level of end joining in the absence of other phosphory-
lations.) Overall, the data conﬁrm the importance of
ABCDE phosphorylation in promoting DNA-PK-
mediated end joining, but suggest that there are additional
DNA-PK phosphorylation targets that are as important
as ABCDE cluster, if not moreso. Histone H1 may be one
such target (22).
Because DNA-PKcs is a large and complex protein, any
comparisons among the wild-type and mutant forms of
the enzyme are potentially complicated by the possibility
that diﬀerences in protein stability rather than in
phosphorylation status could account for the observed
diﬀerences in end-joining eﬃciency. However, we have not
seen any indication of diﬀerences in stability, and all three
alleles have similar levels of kinase activity. In fact, in
some assays, such as DNA end protection and X4L4
recruitment, the A6 protein (which is least active in end
joining) is more active than the D6 protein (6), consistent
with the proposal that it more strongly binds to and
sequesters the DNA end. Extreme care was taken that the
three alleles of DNA-PKcs were puriﬁed, stored and
aliquotted identically. Moreover, although a single batch
of each form of DNA-PKcs was used in all experiments
in Figures 1–4, the previously reported diﬀerences in
biochemical activities were seen consistently with at least
two batches of each allele (Ramsden,D.A., unpublished
data). Nevertheless, the possibility that one or both of the
mutant proteins tends to spontaneously degrade in a way
that compromises its end-joining activity but not its kinase
activity, cannot be deﬁnitively excluded.
Recently, it has been reported that in irradiated cells
(10Gy) the ABCDE cluster is phosphorylated by ATM
rather than DNA-PK (23). However, if such ATM-
mediated phosphorylation is required for DNA repair, it
is diﬃcult to reconcile the small defect in DSB rejoining
seen in ATM-deﬁcient cells (24–26) with the much larger
deﬁcit seen in cells harboring DNA-PKcs-A6 (5). The
distinct lack of an inhibitory eﬀect of KU55933 on end
joining at concentrations known to block ATM kinase
activity (Figures 1 and 2) suggests that, at least in cell
extracts, the ABCDE phosphorylation that is functionally
relevant for repair is carried out by DNA-PK rather than
ATM. At survivable levels of damage in intact cells,
DNA-PK autophosphorylation might be transient and
involve only an extremely small number of DNA-PKcs
molecules actually bound to DSB ends, and so might not
be detected in any direct phosphorylation assays.
A second ‘PQR’ cluster of ﬁve phosphorylated serines
(2023, 2029, 2041, 2053, 2056) has been identiﬁed in DNA-
PKcs, and in contrast to ABCDE, phosphorylation of these
sites appears to decrease accessibility of DNA ends (27).
However, even simultaneous S!A substitutions at all
ﬁve PQR sites confers only slight radiosensitivity. A
threonine!alanine substitution at a newly identiﬁed
C-terminal site, T3950, confers radiosensitivity intermedi-
ate between normal and DNA-PKcs-deﬁcient cells (28),
but while in vivo phosphorylation at this site has been
demonstrated it is not known whether the phosphory-
lation is catalyzed by DNA-PK. Overall, the available
data suggest that functionally relevant phosphorylation
occurs at a large number of sites on DNA-PKcs, and that
while no single site is essential, some are more important
than others. Thus, while elimination of phosphorylation
throughout the ABCDE cluster (as in DNA-PKcs-A6)
reduces end joining to a low level, elimination of
phosphorylation at all non-ABCDE sites (DNA-PKcs-
D6 plus KU57788) reduces end joining to an undetectable
level (Figures 3 and 4). Interpretation of results with the
D6 mutant is complicated by the possibility that optimal
end joining may require not only that these sites be
phosphorylated, but that they be phosphorylated/
dephosphorylated in a speciﬁc order or at a speciﬁc
stage of the end-joining pathway. Although the assays
with the gapped substrate can potentially discriminate
between the gap-ﬁlling step and the ﬁnal ligation step,
mutations in the ABCDE cluster as well as DNA-PK/
ATM inhibitors appear to aﬀect both steps about equally,
consistent with a model where ABCDE phosphorylation
precedes both steps.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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